Jul 13 |
Eli Lilly’s GLP-1 impact on ResMed is overblown: Barron’s
|
Jul 13 |
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
|
Jul 13 |
Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
|
Jul 12 |
Lilly expecting Q2 IPR&D pre-tax charge of around $0.14 per share: report
|
Jul 12 |
These are the weight loss drug stocks with the most upside - SA Sentiment Survey
|
Jul 12 |
Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory
|
Jul 12 |
Pharma Stock Roundup: LLY to Buy Morphic, PFE Advances Obesity Drug Development
|
Jul 12 |
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
Jul 12 |
Should You Buy Eli Lilly Stock After Another Major Win?
|
Jul 11 |
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
|